Patents Assigned to Fortress Biotech, Inc.
  • Cyproterone acetate compositions and uses thereof
    Patent number: 11376263
    Abstract: Provided herein are oral drug preparations including cyproterone acetate and ethinylestradiol, dosing regimen for the drug preparations, and methods of treating diseases. The methods provided include the administration of the oral drug preparation to treat one or more symptoms of hyperandrogenic conditions or hyperandrogenic activities, to provide contraception, and to reduce a risk of vascular thromboembolism (VTE) in a subject.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: July 5, 2022
    Assignee: Fortress Biotech, Inc.
    Inventors: Lindsay Rosenwald, Lei Zheng, Lucy Lu